The Medical Verdict: US’s Top Physician Group Reasserts the Necessity of Trans Healthcare


Although recent reports suggested otherwise, the American Medical Association said it hasn’t changed its policy on gender-affirming care and reaffirmed that such treatment for transgender minors, including surgery when clinically indicated, is medically necessary. That clarification directly addressed inaccurate media claims that the nation’s largest physician organization had aligned itself with more restrictive recommendations. Instead, the AMA stated that existing policy remains in force and continues to support evidence-based treatment pathways developed through individualized assessment. The association’s statement carries significant policy implications because hospitals, insurers, and regulators often interpret national medical guidance as a benchmark for lawful and ethical care. By restating its position, the AMA sought to protect clinical access and reduce institutional uncertainty for patients, families, and treating physicians.
The response came from AMA Board Chair Dr. David H. Aizuss, who said the organization doesn’t endorse the February position statement issued by the American Society of Plastic Surgeons. That ASPS document recommended delaying gender-related chest, genital, and facial surgeries until at least age 19. The AMA rejected any suggestion that such a recommendation altered its own standards. Its intervention was designed to preserve access to care consistent with established professional guidance, not to narrow it.
The AMA’s clarification also served a practical purpose: preventing confusion that could prompt hospitals or health systems to restrict services for transgender patients. In the current climate, where political campaigns and funding pressures increasingly target gender-affirming care, ambiguity can quickly influence administrative decisions. The association emphasized that clinical decisions should remain grounded in physician judgment, patient needs, and family involvement. In doing so, it reinforced a core medical principle: treatment standards must follow evidence and individualized clinical evaluation, not misreporting or external ideological pressure. That message places patient welfare and professional autonomy at the center of care.
News and AdvocacyMarch 28, 2026The Medical Verdict: US’s Top Physician Group Reasserts the Necessity of Trans Healthcare
News and AdvocacyMarch 28, 2026Five Years Behind Bars: Idaho Republicans Criminalize Transgender Bathroom Access in Sweeping Bill
Featured PostsMarch 28, 2026Sweeping and Unopposed: The Kentucky Legislation Targeting Trans Teachers and Classifying Identity as Illness
News and AdvocacyMarch 26, 2026Transgender Women Athletes Locked Out as IOC Redefines Who Can Compete in Women’s Events